EdwardLebovicsMD

Advanced Endoscopic Interventional, Biliary Tract Disease, Hepatology & Liver Transplantation, Inflammatory Bowel Disease

Gastrointestinal and Hepatobiliary Consultants P.C. (dba C.W.P.W.)

Join to view full profile

Dr. Lebovics is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lebovics' full profile

Already have an account?

Office
Ambulatory care Pavilion, 3rd floor
100 Woods Road
Valhalla, NY 10595
Phone+1 914-533-4111

Fax+1 914-449-1940

Summary

Dr. Lebovics is the Upham Professor of Gastroenterology and Director of the Sarah C. Upham Division of Gastroenterology and Hepatobiliary Diseases at New York Medical College and Vice Chair for Clinical Affairs of the Department of Medicine. He is Chief of the Section of Gastroenterology and Hepatobiliary Diseases at Westchester Medical Center. He directed the gastroenterology fellowship training program 1997-2017. He serves on the Executive Committee of the Faculty Senate of NYMC and is a past-president of the Medical Executive Board of WMC.

Dr. Lebovics’ clinical expertise and research have made significant contributions in the fields of gastrointestinal and liver disease. His special interests include advanced therapeutic endoscopy, hepatitis C virus infection, chronic liver diseases, and inflammatory bowel disease. He has authored numerous articles and book chapters and delivered many invited lectures.

His achievements have been recognized by a Certificate of Special Congressional Recognition and by election to Fellowship at the American College of Physicians, American College of Gastroenterology and American Gastroenterological Association. He has been frequently listed amongst “Top Doctors” by New York Magazine and various other publications. Medical students and residents have also recognized his commitment to teaching through Excellence in Teaching Awards.

Education & Training

NYMC-Westchester1984 - 1986
Liver Diseases, Mt Sinai Hospital of CUNY1983 - 1984
Washington University School of Medicine1981 - 1983
Washington University School of Medicine1980 - 1981
New York University School of MedicineClass of 1980
Yeshiva UniversityB.A., Summa Cum Laude, 1976

Certifications & Licensure

NY State Medical License 1983 - 2025
CT State Medical License 1989 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians)
Westchester Magazine: Top Doctors Castle Connolly, 2004-2018
Top Doctors: New York Metro Area Castle Connolly, 2002-2018
Best Doctors in New York New York Magazine, Gastroenterology, 2004-2005, 2007, 2009, 2011-2016
Community Service Award Yeshiva Ketana of Manhattan, 2004
Community Service Award Yeshiva Telshe Riverdale, 2001
Excellence in Teaching Award Department of Medicine, New York Medical College, 1997
Kiryas Joel Medical Devotion Award 1996
Certificate of Special Congressional Recognition 1996
Join now to see all

Publications & Presentations

PubMed

2 citations
Fontan-Associated Liver Disease: A Review.
Gabriel Heering, Nachum Lebovics, Raksheeth Agarwal, William H Frishman, Edward Lebovics
Cardiology in Review. 2024-03-13
3 citations
The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis.
Michael Broker, Shalom Frager, Nayan Patel, Edward Lebovics, William H. Frishman
Cardiology in Review. 2021-07-01
19 citations
Successful transplantation of organs from a deceased donor with early SARS-CoV-2 infection
Abhay Dhand, Alan Gass, Seigo Nishida, Masashi Kai, Karen Berger
American Journal of Transplantation. 2021-05-31

Journal Articles

Endoscopic laser therapy of GI bleeding.
Heier SK, Lebovics E, Rosenthal WS, N Eng J Med 1988; 318:185-6 (letter)
Photodynamic therapy of esophageal malignancy using dihematoporphyhrin ethers.
Heier SK, Lebovics E, Rothman K, Rosenthal WS, Bollettino dell'Istituto Dermatologico S. Gallicano 1988; 13:195-202
Breakthrough of interferon therapy.
Lebovics E, Dworkin BM, Rosenthal WS, AM J Gastro 1996; 91, No10:2250. (letter)
Observation on intrarenal and intraperitoneal pressures in patients with tense ascites: feasibility of unassisted ascited drainage into the urinary tract.
Rozenblit G, Lebovics E, Savino J, Rundback J, Bashir S., Min Invas Ther & Allied Technol 1997;6:83-86
SEN viruses and treatment response in chronic hepatitis C virus.
Rigas B, Donahue P, Wittkowski KM, Lebovics E, Lancet 2002;359:1780 (letter)
Hepatitis non-A-E.
Reich D, Lebovics E, Hepatitis Index and Reviews 2004; 5:2
Postmenopausal Hormone Replacement Therapy and the Risks of Calculous.
Kalala S, Kirshna M, Shah R, Lebovics E, Frishman W, Clinical Geriatrics
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, ..., N Engl J Med. 2009;361:580-93
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK,..., Gastroenterology 2010 ;139:1602-11
Telaprevir for previously untreated chronic hepatitis C virus infection.
Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Ter..., N Engl J Med. 2011;364:2405-16
Racial differences in hepatitis C treatment eligibility.
Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Novie..., Hepatology. 2011;54:70-8
Join now to see all

Books/Book Chapters

Hepatitis C in the healthcare setting.
Chapter: II. Seroprevalence among hemodialysis staff and patients in suburban New York City
Page 5 - 8Lebovics E, Calmann M, O'Brien TAAm J Infect Control
AIDS and Other Manifestations of HTLV-III infection.
Chapter: The Liver in AIDS
Page 767 - 782Lebovics E, Dworkin BEditors: Wormser GP.Noves Publications, Park Ridge, N.J

Abstracts/Posters

Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.
Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW, Transplantation 1999;68:307-9
Defining the normal diameter of the intrahepatic bile ducts on ERCP.
Lee Y, Ligresti R, Kannam H, Kaza C, Lebovics E, Gastrointestinal Endoscopy 2003, Presented at DDW, Orlando FL
Non- alcoholic steatohepatitis (NASH) increases hepatic inflammation and fibrosis in chronic hepatitis C (CHC). Final results.
Lee Y, Ligresti R, Kalala S, Mackey J, Bloom P, Elhosseiny A, Rigas B, Lebovics E, Gastroenterology 2003;124:A-744, Presented at DDW, Orlando, FL
Is severity of inflammation and fibrosis in chronic hepatitis C (CHC) aggravated by non-alcoholic fatty liver (NAFL) or steatohepatitis (NASH).
Lee Y, Lebovics E, Bloom P, Mackey J, Elhosseiny A, Hirsch J, Kaza C, Ligresti R, Rigas B, Hepatology 2002;36:359A
Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT: Final results.
Jacobson IM, Russo MW, Lebovics E, Esposito S, Tobias H, Klion F, Brown RS, Dietrich D, Gastroenterology 2002;122:A-627, Presented at DDW, San Francisco, CA
Induction Interferon alpha 2b 5MU daily for 4 weeks followed by combination Interferon- Ribavirin versus interferon-Ribavirin without induction for previously untreate...
Lebovics E, Castillo E, Rampersaud P, Hirsch J, Casellas A, McFarlane C, Esposito S., Tobias H, Geders J, Jacobson I, Klion F, Wolf D, Gastroenterology 2001; 120: A570, Presented at DDW, Atlanta, GA
Pegylated InterferonAlfa-2b Plus Ribavirin In Patients With Chronic Hepatitis C: A Trial In Prior Nonresponders to Interferon Monotherapy of Combination Therapy, And I...
Jacobson I, Russo M, Brown R, Lebovics E, Min A, Esposito S, Tobias H, Klion F, Pizov O, Brass C, and The Ny Peg Intron Study Group, Gastroenterology 2001; 120:A383
Induction Interferon ?2b 5 MU Daily for 4 Weeks Followed by Combination Interferon-Ribavirin Versus Interferon-Ribavirin Without Induction for Previously Untreated Pat...
Lebovics E, Raghuraman U, Rampersaud P, Castillo E, Casellas A, McFarlane C, Esposito S, Tobias H, Geders J, Jacobson I, Klion F, Min A, Gastroenterology 1999;116:A1237, Presented at Digestive Disease Week Annual Meeting San Diego, CA
Role of early ERCP and sphincterotomy in the management of acute pancreatitis.
Sheikh AM, Warshafsky S, Wolf DC, Lebovics E, Gastroenterology 1999;116:A1237, Presented at the Annual Meeting of the American Gastroenterological Association (2000)
Interferon alfa-2b and Ribavirin in treatment-naïve patients with chronic Hepatitis C and normal ALT levels.
Jacobson IM, Russo M., Lebovics E, Hepatology 1999; 30:459A
No-donating aspirin modulates MAP kinase signaling in human colon cancer cells: Implications for its growth inhibitory effect.
Hundley T, Harley J, Lebovics E, Rigas B, Gastroenterology, April 2003; 124(4):A-281, Presented at DDW, Orlando, FL
Does Hypertryglyceridemia During Interferon Therapy of Chronic Hepatitis C Account for Discordant Biochemical and Virologic Responses?
Lebovics E, Sachdeva N, Kapur S, Sachdeva A, Bansal A, Shaw T, Reddy R, Wolf DC, Dworkin B, Rosenthal R, Casellas A, McFarlane C, Gastroenterology 1999; 116:A1237, Presented at Digestive Disease Week Annual Meeting, Washington
Celiac Sprue presenting as decompensated cirrhosis: A reversible cause of "liver failure".
Lebovics E, Lewis C, Rehman R, Dworkin B, Wolf DC, Rosenthal WS, Gastroenterology 1998; 114:A1285
Early ERCP in the management of acute biliary pancreatitis: A meta analysis.
Sheikh A, Lebovics E, Warshafsky S, Dworkin B, Wolf DC, Rosenthal WS, Gastroenterology 1998; 114:A497
Transmesenteric transfemoral intrahepatic portosystemic shunt (tmTIPS): Predictors of in-hospital outcome.
Krishan R, Raghuraman U, Ouseph B, Chou E, Rea D, Lebovics E, Rozenblit G, Poplausky M, Rundback J, Del Guercio LRM, Dworkin B, Rosenthal W, Wolf DC, Gastroenterology 1998;114:A1280, the Annual Meeting of the American Gastroenterological Association, New Orleans, LA
Hepatitis B core antibody (HBcAb) positivity in patients with chronic hepatitis C (CHC): Does it impact on clinical and pathologic presentation and response to therapy?.
Kaza C, Sachdeva N, Lebovics E, Kapur S, Kessler S, Singh V, Dworkin B, Wolf DC, Rosenthal WS, Gastroenterology 1998;114;A1270
Colonic neoplasia in women with carcinoma of the breast: A colonoscopic case control study.
Dworkin B, Hsieh A, Karmen C, Lebovics E, Rosenthal WS, Wolf DC, Gastroenterology 1998; 114:A588
Body composition in patients with compensated hepatitis C, compared to advanced cirrhotics and normal controls.
Dworkin B, Wolf DC, Raghuraman U, Hui K, Chou E, Rea D, Lebovics E, Rosenthal WS, Gastroenterology 1998;114:A497
Hepatitis B core antibody (HBcAb) positivity in patients with chronic hepatitis C (CHC): Does it impact on clinical and pathologic presentation and response therapy?
Kaza C, Sachdeva N, Lebovics E, Kapur S, Kessler S, Singh V, Dworkin B, Wolf DC, Rosenthal WS, Gastroenterology 1998; 114:A1270
The Role of Clinical and Endosonographic Features in Predicting the Accuracy of Endoscopic Ultrasound Guided Fine Needle Aspiration.
Ross C, Galandauer I, Mund R, Lebovics E, Pais S, American Journal of Gastroenterology 2010;105:S61
The “TMA Blip”: Clinical significance of transient positivity of hepatitis C virus (HCV) transcription- mediated amplification (TMA) during periods of polymerase chain...
DiGiorno C, Deng K, Casellas, A, McEwen C, Hirsch J, Wolf DC, Lebovics E, Gastroenterology 2008; 134, Presented at DDW, San Francisco, CA
Pegylated Interferon alpha-2b plus Ribavirin in patients with chronic Hepatitis C: A trial in prior non-responders to Interferon monotherapy or combination therapy and...
Jacobson I, Furquaan A., Russo M, Brown R, Lebovics E, Min A, Esposito S, Brau N, Tobias H, Klion F, Bini E, Brodsky N, Rovner D, Brass C, NY PEG-Intron Study Group, Gastroenterology 2003;124(4):A-714, Presented at DDW, Orlando, FL
Pegylated interferon alpha-2b plus ribavirin in patients with chronic hepatitis C:A trial in prior non-responders to interferon monotherapy or combination therapy and ...
Jacobson IM, Russo MW, Brown RS, Lebovics E, Min A, Esposito S., Tobias H, Klion F, Rovner D, Brass C, Hepatology 2002;36:358A, Presented at AASLD Annual Meeting, Boston, MA
Pegylated interferon alpha-2b plus ribavirin in patients with chronic hepatitis C:A trial in prior non-responders to interferon monotherapy or combination therapy and ...
Jacobson IM, Russo MW, Brown RS, Lebovics E, Min A, Esposito S., Tobias H, Klion F, Rovner D, Brass C, Gastroenterology 2002;122:A-626, Presented at DDW, San Francisco, CA
Pegylated interferon alpha-2b plus ribavirin in patients with chronic hepatitis C:A trial in prior non-responders to interferon monotherapy or combination therapy and ...
Jacobson IM, Russo MW, Brown RS, Lebovics E, Min A, Esposito S., Tobias H, Klion F, Pizov O, Brass C, Hepatology 2001;34:338A, Presented at AASLD Annual Meeting, Dallas, Texas
Join now to see all

Lectures

The Challenge of the Hepatitis C Non-Responder.
Queens General Hospital, Dept. of Medicine
Advances in the Management of Chronic Hepatitis C.
Good Samaritan Hospital, Suffern NY, Medical Grand Rounds
The Burden of Illness in Patients with IBS.
Novartis Pharmaceuticals
Hepatitis C in the Pediatric Population.
NYMC, Department of Pediatrics, Grand Rounds
Hepatitis C: An Overview of Treatment Options.
American Liver Foundation – Liver Update
Progress in the Management of Chronic Hepatitis C.
The Nurse Practitioner Association
Newer Treatments in Hepatitis B.
Westchester Medical Center
Treatment Options for the HCV Nonresponder.
VA Hospital, Bronx, NY
Capsule Endoscopy: The Fantastic Voyage.
NYMC, Dept. of Medicine
Capsule Endoscopy: The Fantastic Voyage.
NYMC, Dept. of Surgery
New Trends in the Evaluation and Treatment of Hepatitis B and C.
Community Choice Health Plan of Westchester and Sound Shore Medical Center of Westchester
Update on Management of chronic hepatitis C.
Our Lady of Mercy Medical Center, Dept. of Medicine Grand Rounds
CT Colonography: Virtual Reality.
NYMC Dept. of Medicine Grand Rounds
Baffled by NAFLD? Why You Should Care and What You Should Do.
Bar-Ilan University, Ramat Gan, Israel
Baffled by NAFLD? Why You Should Care and What You Should Do.
Westchester Medical Center, Dept. of Medicine Grand Rounds
Hepatitis B Treatment Guidelines Review.
Metropolitan Hospital, Dept. of Medicine Grand Rounds
Hepatitis B Treatment Guidelines Review.
Sound Shore Medical Center of Westchester, Dept. of Medicine Grand Rounds
The 30th Anniversary of the PEG: Medical , Ethical and Legal Issues.
Westechester Medical Center, Dept. of Medicine Grand Rounds
Direct Acting Antiviral Therapy of Chronic Hepatitis C: The Dawn of a New Era.
Lincoln Hospital, Dept. of Medicine Grand Rounds
Hepatitis C: Reflecting Back, Looking Forward.
Westchester Medical Center, Dept. of Medicine Grand Rounds
Chronic Hepatitis C, The Silent Epidemic.
Ulster County Medical Society (Kingston)
Update on Viral Hepatitis.
Peekskill Health Center
Hepatitis B: New Approaches to Diagnosis and Management.
Mt. Vernon Hospital
Advances in Management of Chronic Viral Hepatitis.
Pascack Valley Hospital
Progress in Inflammatory Bowel Disease .
Crohn’s and Colitis Foundation of America
Join now to see all